ArticleJournal of medicinal chemistry2010

Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.

Balaram Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.